Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience.

Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, Hua B, Liu B, Lu L, Gilkeson GS, Silver RM, Chen W, Shi S, Sun L.

Cell Transplant. 2013;22(12):2267-77. doi: 10.3727/096368911X582769.

PMID:
24388428
2.

Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study.

Wang D, Li J, Zhang Y, Zhang M, Chen J, Li X, Hu X, Jiang S, Shi S, Sun L.

Arthritis Res Ther. 2014 Mar 25;16(2):R79. doi: 10.1186/ar4520.

3.

Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.

Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, Lu L, Shi S.

Arthritis Rheum. 2010 Aug;62(8):2467-75. doi: 10.1002/art.27548.

4.

Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.

Gu F, Wang D, Zhang H, Feng X, Gilkeson GS, Shi S, Sun L.

Clin Rheumatol. 2014 Nov;33(11):1611-9. doi: 10.1007/s10067-014-2754-4. Epub 2014 Aug 14.

PMID:
25119864
5.

Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus.

Wang D, Akiyama K, Zhang H, Yamaza T, Li X, Feng X, Wang H, Hua B, Liu B, Xu H, Chen W, Shi S, Sun L.

Clin Dev Immunol. 2012;2012:273291. doi: 10.1155/2012/273291. Epub 2012 Jul 9.

6.

Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus.

Shi D, Wang D, Li X, Zhang H, Che N, Lu Z, Sun L.

Clin Rheumatol. 2012 May;31(5):841-6. doi: 10.1007/s10067-012-1943-2.

PMID:
22302582
7.

[Therapeutic effects of umbilical cord mesenchymal stem cells transplantation on systemic lupus erythematosus].

Yang GX, Pan LP, Zhou QY, Song W, Chen ZQ, Wang CX, Wu YB, Wang X, Chen Q.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Mar;45(2):338-41, 350. Chinese.

PMID:
24749369
8.

Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.

Ma L, Aijima R, Hoshino Y, Yamaza H, Tomoda E, Tanaka Y, Sonoda S, Song G, Zhao W, Nonaka K, Shi S, Yamaza T.

Stem Cell Res Ther. 2015 May 27;6:104. doi: 10.1186/s13287-015-0091-4.

9.

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.

Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, Verda L, Krosnjar N, Quigley K, Yaung K, Villa Bs M, Takahashi M, Jovanovic B, Oyama Y.

JAMA. 2006 Feb 1;295(5):527-35.

PMID:
16449618
10.

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.

Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S.

Stem Cells. 2009 Jun;27(6):1421-32. doi: 10.1002/stem.68.

11.

Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.

Sui W, Hou X, Che W, Chen J, Ou M, Xue W, Dai Y.

Clin Immunol. 2013 Aug;148(2):186-97. doi: 10.1016/j.clim.2013.05.014. Epub 2013 May 30. Review.

PMID:
23770628
12.

Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus.

Li X, Wang D, Liang J, Zhang H, Sun L.

Bone Marrow Transplant. 2013 Apr;48(4):544-50. doi: 10.1038/bmt.2012.184. Epub 2012 Oct 15.

PMID:
23064040
13.

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.

Reinders ME, Dreyer GJ, Bank JR, Roelofs H, Heidt S, Roelen DL, Zandvliet ML, Huurman VA, Fibbe WE, van Kooten C, Claas FH, Rabelink TJ, de Fijter JW.

J Transl Med. 2015 Nov 4;13:344. doi: 10.1186/s12967-015-0700-0.

14.

Differential efficacy of human mesenchymal stem cells based on source of origin.

Collins E, Gu F, Qi M, Molano I, Ruiz P, Sun L, Gilkeson GS.

J Immunol. 2014 Nov 1;193(9):4381-90. doi: 10.4049/jimmunol.1401636. Epub 2014 Oct 1.

15.

Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.

Wang Q, Qian S, Li J, Che N, Gu L, Wang Q, Liu Y, Mei H.

Lupus. 2015 Oct;24(11):1221-6. doi: 10.1177/0961203315583541. Epub 2015 Apr 24.

PMID:
25914407
16.

Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.

Traynor AE, Barr WG, Rosa RM, Rodriguez J, Oyama Y, Baker S, Brush M, Burt RK.

Arthritis Rheum. 2002 Nov;46(11):2917-23.

17.

Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.

Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, Hou Y, Lu L, Gilkeson GS, Silver RM, Zeng X, Shi S, Sun L.

Lupus. 2010 Nov;19(13):1502-14. doi: 10.1177/0961203310373782. Epub 2010 Jul 20.

PMID:
20647254
18.

Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.

Liu X, Wu M, Peng Y, Chen X, Sun J, Huang F, Fan Z, Zhou H, Wu X, Yu G, Zhang X, Li Y, Xiao Y, Song C, Xiang AP, Liu Q.

Cell Transplant. 2014;23(9):1087-98. doi: 10.3727/096368912X661319.

PMID:
23294601
19.

Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation.

Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, Hou Y, Gilkeson G, Lu L, Sun L.

Cell Transplant. 2013;22(12):2279-90. doi: 10.3727/096368912X658692. Epub 2012 Oct 31.

PMID:
23127285
20.

Bone marrow transplantation: a new strategy for intractable diseases.

Ikehara S.

Drugs Today (Barc). 2002 Feb;38(2):103-11. Review.

PMID:
12532188
Items per page

Supplemental Content

Write to the Help Desk